Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of TollB-001 tablets in diffuse cutaneous systemic sclerosis
CTR20261937Phase 2Active
- Sponsor
- 北京拓领博泰生物科技
- Start
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tollb-001 in systemic sclerosis (SSc), sponsored by 北京拓领博泰生物科技. Started Aug 2026; status: active.
02
Drugs
tollb-001
03
Conditions
systemic sclerosis (SSc)
Beyond the preview
Go deeper on CTR20261937.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20261937.